P. Gentilini et al., LONG COURSE AND PROGNOSTIC FACTORS OF VIRUS-INDUCED CIRRHOSIS OF THE LIVER, The American journal of gastroenterology, 92(1), 1997, pp. 66-72
Objectives: Chronic infection by hepatitis B virus (HBV) and hepatitis
C virus (HCV) is now recognized as a major cause of liver cirrhosis.
This study was aimed at evaluating the natural history of the disease
in a large series of Italian patients with HBV- and HCV-related cirrho
sis without portal hypertension at entry. Methods: The clinical record
s of 405 patients (233 males, mean age 54 +/- 9 yr) with histologicall
y proven cirrhosis (321 with HCV-related and 84 with HBV-related cirrh
osis) and no clinical evidence of portal hypertension at entry were re
trospectively examined to evaluate the occurrence of complications and
the cumulative mortality rate during follow-up. Results: Patients had
a mean follow-up of 8 +/- 3 yr. The cumulative survival rate was 99.1
% at 5 yr, 76.8% at 10 yr, and 49.4% at 15 yr. The age-adjusted death
rate was 3.14 and 2.84 times higher than in the general Italian popula
tion in men and women, respectively. Only the bilirubin level was an i
ndependent indicator of survival. Esophageal varices, ascites, jaundic
e, hemorrhage, hepatic encephalopathy, and hepatocellular carcinoma si
gnificantly reduced the survival rate (major complications), whereas t
hrombocytopenia, diabetes, and cholelithiasis did not affect survival
(minor complications). The incidence of hepatocellular carcinoma was s
imilar in patients with either HBV- or HCV-related disease and was qui
te frequent, especially in males. Conclusions: This study demonstrates
that the course of virus-induced liver cirrhosis is not influenced by
the etiology of the disease and that the occurrence of complications
significantly shortens life expectancy. The longer survival rate obser
ved in this study is probably due to the fact that cirrhosis was here
recognized by liver biopsy in the absence of clinical evidence of port
al hypertension.